A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. 1981

J L Magnani, and M Brockhaus, and D F Smith, and V Ginsburg, and M Blaszczyk, and K F Mitchell, and Z Steplewski, and H Koprowski

The antigen of a monoclonal antibody that is specific for cells of human carcinoma of the colon is a monosialoganglioside as determined by the direct binding of antibody to thin-layer chromatograms of total lipid extracts of tissues. Binding of antibody to chromatograms is detected by autoradiography after the application of iodine-125-labeled F(ab')2 of rabbit immunoglobulin G antibodies to mouse immunoglobulins.

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005732 Gangliosides A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) Ganglioside,Sialoglycosphingolipids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody

Related Publications

J L Magnani, and M Brockhaus, and D F Smith, and V Ginsburg, and M Blaszczyk, and K F Mitchell, and Z Steplewski, and H Koprowski
November 1985, Journal of the National Cancer Institute,
J L Magnani, and M Brockhaus, and D F Smith, and V Ginsburg, and M Blaszczyk, and K F Mitchell, and Z Steplewski, and H Koprowski
September 1986, Journal of the National Cancer Institute,
J L Magnani, and M Brockhaus, and D F Smith, and V Ginsburg, and M Blaszczyk, and K F Mitchell, and Z Steplewski, and H Koprowski
June 1994, Hybridoma,
J L Magnani, and M Brockhaus, and D F Smith, and V Ginsburg, and M Blaszczyk, and K F Mitchell, and Z Steplewski, and H Koprowski
January 1988, The International journal of biological markers,
J L Magnani, and M Brockhaus, and D F Smith, and V Ginsburg, and M Blaszczyk, and K F Mitchell, and Z Steplewski, and H Koprowski
August 1987, European journal of cancer & clinical oncology,
J L Magnani, and M Brockhaus, and D F Smith, and V Ginsburg, and M Blaszczyk, and K F Mitchell, and Z Steplewski, and H Koprowski
June 1987, Cancer,
J L Magnani, and M Brockhaus, and D F Smith, and V Ginsburg, and M Blaszczyk, and K F Mitchell, and Z Steplewski, and H Koprowski
January 1985, Hybridoma,
J L Magnani, and M Brockhaus, and D F Smith, and V Ginsburg, and M Blaszczyk, and K F Mitchell, and Z Steplewski, and H Koprowski
December 1981, Blood,
J L Magnani, and M Brockhaus, and D F Smith, and V Ginsburg, and M Blaszczyk, and K F Mitchell, and Z Steplewski, and H Koprowski
May 1989, Journal of biochemistry,
J L Magnani, and M Brockhaus, and D F Smith, and V Ginsburg, and M Blaszczyk, and K F Mitchell, and Z Steplewski, and H Koprowski
February 1991, Cancer research,
Copied contents to your clipboard!